Almirall SA is a global biopharmaceutical company, which is focused on skin health. The company is headquartered in Barcelona, Barcelona and currently employs 2,084 full-time employees. The company went IPO on 2007-04-19. The firm focuses on development and marketing of drugs applied in various therapeutic areas, such as nervous system, gastrointestinal, dermatological, respiratory system, antiinfectives, as well as antineoplastic and immunomodulating agents. The firm's activities are divided into four business segments: Own network, which focuses on the commercialization of pharmaceuticals through own brand names; Licenses, which sells product rights to third parties; Research and development (R&D), which is responsible for the creation of drug candidates, as well as Dermatology, which includes sale of dermatological medicines in the United States. The firm operates through numerous subsidiaries in Europe, the Americas, Africa, Asia and Australia.
Follow-Up Questions
Almirall SA 'in CEO'su kimdir?
Mr. Carlos Gallardo Pique 2014 'den beri şirketle birlikte olan Almirall SA 'in Executive Chairman of the Board 'ıdır.
LBTSF hissesinin fiyat performansı nasıl?
LBTSF 'in mevcut fiyatı $0 'dir, son işlem günde 0% decreased etti.
Almirall SA için ana iş temaları veya sektörler nelerdir?
Almirall SA Pharmaceuticals endüstrisine ait ve sektör Health Care 'dir
Almirall SA 'in piyasa değerlemesi nedir?
Almirall SA 'in mevcut piyasa değerlemesi $0 'dir
Almirall SA al, sat, yoksa beklemeli mi?
Wall Street analistlerine göre, 15 analist Almirall SA için analist derecelendirmeleri gerçekleştirdi, bunlar 3 güçlü al, 9 al, 3 tut, 0 sat ve 3 güçlü sat içermektedir
